Preterm Birth and PROM Testing Market Growth & Trends [2031]

Report Description

Preterm Birth and PROM Testing Market Outlook 2031

The global preterm birth and PROM testing market size was USD 1.2 Bn in 2022 and is likely to reach USD 2.4 Bn by 2031, expanding at a CAGR of 8.1% during 2023–2031. The market growth is attributed to the advancements in diagnostic technologies and the increasing average age of pregnant women.

Increasing adoption of telehealth and remote monitoring solutions is driving preterm birth and PROM testing market growth. Rising development of point-of-care testing devices that provide rapid and on-site results, enhances accessibility and convenience for both healthcare providers and patients, especially in resource-limited settings. For instance,

• According to data published by the Centers for Disease Control and Prevention in October 2022, revealed that telemedicine usage was more prevalent among women reaching 42.0% compared to men around 31.7%. Moreover, the number of adults utilizing telemedicine with age increased, starting at 29.4% for adults aged 18–29 and reaching 43.3% for adults aged 65 and over.

Get Free Sample Report

Growing awareness about preterm birth and the availability of PROM testing increases the importance of early testing and intervention. Increasing emphasis on maternal and child health is leading to increased awareness and proactive measures for identifying and managing risks associated with preterm births and PROM. This emphasis is fostering a demand for testing services.

The market report finds that the COVID-19 pandemic affected the market. The COVID-19 pandemic has led to disruptions in healthcare services worldwide. Resources including, medical personnel and facilities, were diverted to address the immediate challenges posed by the pandemic. This diversion has affected routine prenatal care and screenings, including those related to preterm birth and PROM testing. Furthermore, during the pandemic pregnant women infected with the COVID-19 virus are at higher risk of preterm birth, thereby driving a significant demand for preterm birth and PROM testing. For instance,

• According to data published by the National Institute of Health in December 2023, the risk of preterm birth increased from 7.1% to 8.3% between July 2020 and February 2023 due to COVID-19 infection.

Impact of Artificial Intelligence (AI) on the Preterm Birth and PROM Testing Market

Artificial Intelligence (AI) is expected to boost the revenue of the market players in the preterm birth and PROM testing market. This technology analyzes a variety of data, including patient history, genetic information, and prenatal monitoring data, to develop predictive models for identifying women at a high risk of preterm birth or PROM. This led to early intervention and improved outcomes.

Preterm Birth and PROM Testing Market Dynamics

Get Free Sample Report

Major Drivers

Growing prevalence of preterm births is driving the market. Rising number of preterm births has resulted in an increased demand for testing services that identify women at risk of preterm labor. Healthcare providers and pregnant individuals seek preterm birth and PROM testing to assess and manage potential risks. Furthermore, awareness campaigns and educational efforts contribute to high patient awareness and demand for preterm birth and PROM testing. For instance,

• In May 2023, the World Health Organization revealed that the prevalence of preterm birth varies globally, with rates ranging from 4% to 16% of infants born in 2020.  It is a leading cause of death among children under 5 years of age.

Existing Restraints

High cost of advanced testing hampers the market. The high cost of advanced testing methods makes them less accessible to certain patients, particularly those with limited financial resources. Affordability is a critical factor that influences the adoption of preterm birth and PROM testing. Cost barriers create a gap in access to these diagnostic services.

Emerging Opportunities

Technological advancements create lucrative opportunities in the market. Technological advancements have led to the development of precise and accurate diagnostic tools. This is crucial for identifying subtle markers or indicators associated with preterm birth and PROM while enhancing the reliability of test results. Additionally, advancements in imaging technologies, such as 3D and 4D ultrasound, provide detailed insights into fetal development and the condition of the amniotic sac. This allows healthcare professionals to assess the risk of preterm birth and PROM.

Scope of the Preterm Birth and PROM Testing Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Market Segment Insights

Test Type Segment Analysis

Based on test type, the preterm birth and PROM testing market is divided into biochemical markers, pelvic exam, ultrasound, pooling, nitrazine test, ferning test, and uterine monitoring. The ultrasound segment is expected to hold a dominant share of the market during the projection period, due to the increasing demand for non-invasive tests.

Ultrasound is a non-invasive and safe imaging technique that makes it a preferred choice for prenatal screening. Pregnant individuals and healthcare providers often favor ultrasound, due to its safety profile as compared to invasive procedures. Its widespread adoption and familiarity among healthcare professionals boost its popularity and, thus, the market.

The biochemical markers segment is anticipated to expand at a significant pace in the market, as it offers predictive value in assessing the risk of preterm birth. Biochemical markers, such as fetal fibronectin, are studied for their predictive value in assessing the risk of preterm birth. Elevated levels of certain markers in biological samples, such as vaginal or cervical secretions, indicate an increased risk, allowing for early intervention and management. This encourages manufacturers to introduce projects to enhance mother and newborn health outcomes. For instance,

• In May 2022, Sera Prognostics collaborated with the Newborn Foundation and introduced the Every Mother, Every Baby Project. This initiative aims to increase awareness among clinicians, policymakers, and public health stakeholders about the crucial role of validated biomarker-based preterm risk assessment tests, such as Sera's PreTRM test, in enhancing maternal and newborn health outcomes.

Get Free Sample Report

End-user Segment Analysis

On the basis of end-user, the global market is segregated into hospitals, diagnostic laboratories, and others. The hospitals segment is projected to expand at a high CAGR during the forecast period, as it provides centralized healthcare services and offers specialized care.

Hospitals and clinics are central hubs for comprehensive healthcare services, including prenatal care and testing for preterm birth and PROM. They serve as primary points of contact for pregnant individuals by offering a range of diagnostic services. Hospitals, especially those with maternity units and neonatal care facilities, provide access to specialized care for high-risk pregnancies and preterm births. These facilities often have the expertise and infrastructure required for advanced diagnostic testing and intervention.

The diagnostic laboratories segment is projected to expand at a significant growth rate, due to the presence of specialized testing facilities and focus on providing diagnostic services. Diagnostic laboratories are often equipped with specialized facilities for conducting a wide range of diagnostic tests, including those related to preterm birth and PROM. They primarily focus on providing diagnostic services. This specialization allows them to concentrate on refining testing methods, ensuring accuracy, and staying up-to-date with the latest advancements in diagnostic technologies for preterm birth and PROM.

Get Free Sample Report

Regional Outlook

In terms of region, the global preterm birth and PROM testing market is classified as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America is expected to dominate the market during the projection period, due to the increasing incidence of preterm birth and advancements in medical technologies.

Rising incidence of preterm births in North America is attributed to various factors, such as lifestyle changes, maternal age, multiple pregnancies, such as twins & triplets, and medical conditions. Continuous advancements in medical technologies for the early detection and remote patient monitoring of preterm labor contribute to improving diagnostic tools and methods that enhance the accuracy and efficiency of preterm labor detection. For instance,

• In June 2021, Nuvo Group secured approval from the United States Food and Drug Administration (FDA) for the expanded utility of its INVU. This prescription-initiated remote pregnancy monitoring platform includes a new uterine activity module, enabling remote monitoring of uterine activity.

The market in Asia Pacific is projected to grow rapidly during the forecast period, owing to the high birth rate and increasing maternal health awareness in the region. Asia Pacific is characterized by high birth rates and a large population, which drive the demand for preterm birth and PROM testing services in the region. Improving healthcare infrastructure and rising awareness about the importance of maternal and child health create a demand for prenatal care and testing services.

Get Free Sample Report